摘要
Interleukin-4 （IL-4） promotes lymphocyte survival and protects primary lymphomas from apoptosls. Previous studies reported differential requirements for the signal transducer and activator of transcription 6 （STAT6） and IRS2/phosphati-dylinositol 3 kinase （PI-3K） signaling pathways in mediating the IL-4-induced protection from Fas-mediated apoptosis. In this study, we characterized IL-4-activated signals that suppress anti-IgM-mediated apoptosis and growth arrest of CH31, a model B-cell lymphoma line. In CH31, anti-IgM treatment leads to the loss of mitochondrial membrane poten-tial, phospho-Akt, phospho-CDK2, and c-myc protein. These losses are followed by massive induction of p27^Kip1 protein expression, cell cycle arrest, and apoptosis. Strikingly, IL-4 treatment prevented or reversed these changes. Furthermore, IL-4 suppressed the activation of caspases 9 and 3, and, in contrast to previous reports, induced the phosphorylation （de-activation） of BAD. IL-4 treatment also induced expression of BclxL, a STAT6-dependent gene. Pharmacologic inhibitors and dominant inhibitory forms of PI-3K and Akt abrogated the anti-apoptotic function of IL-4. These results suggest that the IL-4 receptor activates several signaling pathways, with the Akt pathway playing a major role in suppression of the apoptotic program activated by anti-IgM.
